Literature DB >> 28641305

Incidence of Autoimmune Myasthenia Gravis in a Health Maintenance Organization in Buenos Aires, Argentina.

Mariela Bettini1, Marcelo Chaves, Edgardo Cristiano, Vanina Pagotto, Lucia Perez, Diego Giunta, Marcelo Rugiero.   

Abstract

BACKGROUND: Different epidemiological studies, especially in Europe, have estimated the incidence density of myasthenia gravis (MG) to range between 1.7 and 21.3/1,000,000/person-year; however, data from regions such as Latin America are scarce. This study is aimed at estimating the incidence and prevalence of acquired MG in Buenos Aires, Argentina.
METHODS: The study population comprised of affiliates of the Italian Hospital Medical Care Program, a prepaid health maintenance organization located in Buenos Aires. The evaluation method for case detection included a retrospective search from January 1, 2006, through December 31, 2012.
RESULTS: Of the 60 cases identified, 36 (60%) were females. The median age at diagnosis was 69 years (IQR 51.5-79). The mean age at diagnosis was 63.3 years (SD ±20). A total of 28 patients (46.7%) had generalized MG and 32 had ocular MG (53.3%). Thirty five patients (58.3%) had acetylcholine receptor antibodies and 2 (3.3%) had muscle-specific receptor tyrosine kinase antibodies. The crude incidence density (ID) of MG was 61.33 per 1,000,000 person-years (95% CI 47.62-79.99). The adjusted ID for the Argentinean population was 38.8 per 1,000,000 person-years (95% CI 27.09-50.51) and for the Buenos Aires population was 47.49 (95% CI 34.73-60.25).
CONCLUSIONS: The results obtained are similar to those published for other geographical areas.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Epidemiology; Incidence; Myasthenia; Prevalence

Mesh:

Year:  2017        PMID: 28641305     DOI: 10.1159/000477733

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  4 in total

1.  Epidemiology of paraneoplastic neurological syndromes: a population-based study.

Authors:  Alberto Vogrig; Gian Luigi Gigli; Samantha Segatti; Elisa Corazza; Alessandro Marini; Andrea Bernardini; Francesca Valent; Martina Fabris; Francesco Curcio; Francesco Brigo; Donatella Iacono; Paolo Passadore; Michele Rana; Jérôme Honnorat; Mariarosaria Valente
Journal:  J Neurol       Date:  2019-09-24       Impact factor: 4.849

Review 2.  The epidemiology of myasthenia gravis.

Authors:  Ana-Maria Bubuioc; Aigerim Kudebayeva; Saule Turuspekova; Vitalie Lisnic; Maurizio Angelo Leone
Journal:  J Med Life       Date:  2021 Jan-Mar

3.  Trends in melanoma incidence at Hospital Italiano de Buenos Aires, 2007-2016.

Authors:  Adriana Raquel Rinflerch; Victoria Ines Volonteri; María Cecilia Roude; Laura Vanina Pagotto; Melina Pol; Luis Daniel Mazzuoccolo
Journal:  An Bras Dermatol       Date:  2021-11-17       Impact factor: 1.896

4.  Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis.

Authors:  Nader Salari; Behnaz Fatahi; Yalda Bartina; Mohsen Kazeminia; Reza Fatahian; Payam Mohammadi; Shamarina Shohaimi; Masoud Mohammadi
Journal:  J Transl Med       Date:  2021-12-20       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.